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S154Objective: Open repair of descending thoracic aortic and thoracoabdominal aortic aneurysms may carry low
morbidity and mortality, depending on experience of the surgeon and operative technique used. Although tho-
racic endovascular aortic repair is less invasive, its limitations include anatomy and pathology of the aorta, prox-
imity of major branches, and significant complication and reintervention rates. We retrospectively reviewed
a 2-surgeon experience (J.W.F. and J.S.C.) with deep hypothermic circulatory arrest to repair descending
thoracic aortic and thoracoabdominal aortic aneurysms.
Methods: All patients (n ¼ 343) who underwent surgical replacement of descending thoracic aortic or thora-
coabdominal aortic aneurysm with deep hypothermic circulatory arrest from 1995 to 2009 were included. Seg-
mental arteries between T8 and the celiac artery were aggressively reimplanted as indicated. Visceral and renal
artery bypasses were performed for significant stenosis. Concomitant coronary artery bypass grafting was per-
formed if targets were anterior or lateral wall vessels. Lumbar drains were not routinely used but placed post-
operatively on clinical evidence of spinal cord ischemia.
Results: Of 343 patients, 98 had descending thoracic aortic aneurysms, 69 had Crawford type I thoracoabdomi-
nal aortic aneurysms, 111 had type II, 32 had type III, and 33 had type IV. Emergency or urgent operations com-
prised 13% of repairs. Hospital mortalities were 5.0% for all cases, 3.7% for elective cases, and 13.3% for
urgent or emergency cases. Overall incidences were 4.4% for stroke, 3.2% for paraplegia or paraparesis,
1.5% for renal failure requiring dialysis, and 3.5% for tracheostomy. The 1-, 3-, 5-, and 10-year survival rates
were 90%, 79%, 69%, and 54%, respectively.
Conclusions: Surgical repair of descending thoracic aortic and thoracoabdominal aortic aneurysms with deep
hypothermic circulatory arrest carries low operativemorbidity andmortality and excellent early and late survival
rates. These results can be used as a benchmark for future techniques and technologies. (J Thorac Cardiovasc
Surg 2010;140:S154-60)Open repair of descending thoracic aneurysms (DTAs) and
thoracoabdominal aortic aneurysms (TAAAs) continues to
be a challenge for cardiothoracic and vascular surgeons.
As a result of the complexity and significant mortality and
morbidity of the operation, a major shift favoring endovas-
cular repair has been undertaken by many cardiothoracic
and vascular surgeons.1-5 Multiple centers have published
good to excellent results with open DTA and TAAA
repair. With the diversity of open repair techniques andlarian Cardiovascular Surgeonsa and Methodist Research Institute,b Method-
spital, Indianapolis, Ind.
res: John W. Fehrenbacher is a consultant for Cryolife. John Kuhn received
e fees from Grand Rounds Wayne Hospital. Harry Siderys, Colin Terry, and
. Corvera have nothing to disclose with regard to commercial support.
d for publication April 28, 2010; revisions received Aug 10, 2010; accepted
blication Aug 23, 2010.
for reprints: Joel S. Corvera, MD, Clarian Cardiovascular Surgeons, 1801
ate Blvd, Suite 755, Indianapolis, IN 46202 (E-mail: jcorvera@clarian.org).
23/$36.00
ht  2010 by The American Association for Thoracic Surgery
016/j.jtcvs.2010.08.054
The Journal of Thoracic and Cardiovascular Surthe inclusion of different repair techniques in most
studies, however, it is difficult to determine whether any
single technique carries the least mortality and morbidity,
as well as the best long-term results.6-11
Deep hypothermic cardiopulmonary bypass with periods
of circulatory arrest (DHCA) has been used by a limited
number of surgeons as the only technique for replacement
of the descending thoracic and thoracoabdominal aorta and
by others for the more complex aneurysms.12-18 We have
used this technique as the singular therapy for DTAs and
TAAAs for the past 15 years, excluding patients with
traumatic distal arch and descending thoracic aortic
injuries, those with selected acute complicated type III
aortic dissections amenable to endovascular repair, and
patients at very high risk with thoracic aneurysms that are
amenable to endovascular repair.
The minimally invasive nature and early results of tho-
racic endovascular aortic repair have highlighted the impor-
tance of studying the long-term survival and durability of
open DTA and TAAA repairs. In this study, we show thatgery c December 2010
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DHCA ¼ deep hypothermic cardiopulmonary
bypasswith periods of circulatory arrest
DTA ¼ descending thoracic aneurysm
SMA ¼ superior mesenteric artery
TAAA ¼ thoracoabdominal aortic aneurysmDHCA provides optimal end-organ protection during the
operation and has excellent early and late results for com-
plex repairs of DTAs and TAAAs.
MATERIALS AND METHODS
This retrospective study was approved by the institutional review board
of Indiana University–Purdue University and Methodist Hospital, Indian-
apolis, Ind. Because of the retrospective nature of the study, informed con-
sent was waived. All patients (n¼ 343) from January 1, 1995, to December
31, 2009, who underwent descending thoracic aortic replacement or thor-
acoabdominal aortic replacement by either of 2 surgeons (J.W.F. or
J.S.C.) with DHCAwere included in the study. Patients who underwent re-
placement of the descending thoracic or thoracoabdominal aorta with left
heart bypass or full cardiopulmonary bypass without hypothermia or with-
out the use of cardiopulmonary bypass were excluded. Patients who under-
went thoracic endovascular aortic repairs were also excluded. Long-term
survival data were obtained by querying the Social Security Death Index
and by referencing the computerized medical records system at Methodist
Hospital.
Statistical Analysis
All data were summarized with descriptive statistics (mean  SD for
continuous measures and counts with percentages for categoric measures).
Survival estimates were calculated with the Kaplan–Meier method. Obser-
vations for patients who were unavailable for follow-up or who were still
alive as of December 31, 2009, were considered to be censored.Indications for Operation
Elective DTA and TAAA repairs were performed when the thoracic
component of the aneurysm was larger than 5.5 cm or had a growth rate
of greater than 0.5 cm per year. TAAAs were also repaired if the abdominal
component was larger than 5.0 cm. Chronic dissections involving the tho-
racic or thoracoabdominal aorta were repaired if the aneurysmal compo-
nent of the dissected aorta measured 5.0 to 5.5 cm.
Indications for urgent or emergency repair included acute, complicated
type III aortic dissection, malperfusion syndrome, persistent pain despite
adequate blood pressure control, aortic rupture, and aortobronchial or aor-
toesophageal fistula.Preoperative Considerations
All elective patients underwent preoperative coronary catheterization.
Hemodynamically significant left anterior descending or circumflex distri-
bution coronary arteries were bypassed at the time of surgery for DTA or
type I or II TAAA repairs. In the case of type III or IV TAAA, significant
left-sided lesions were treated with percutaneous coronary intervention.
Hemodynamically significant lesions in the right coronary distribution
were treated with percutaneous coronary intervention if amenable. In the
event of severe 3-vessel coronary artery disease, a coronary artery bypass
operation through a sternotomy was completed before the aneurysm repair.
All patients with worse than moderate aortic insufficiency underwentThe Journal of Thoracic and Cardaortic valve replacement before the aneurysm repair. Severe chronic
obstructive pulmonary disease and home oxygen therapy were not contra-
indications for surgery. Severe bronchiectasis or the production of large
amounts of dirty sputum were relative contraindications. Spinal drainage
was not used routinely but was placed only when motor-evoked potentials
did not return to baseline after completion of the operation or when there
were changes in the lower extremity neurologic function or with delayed
paraparesis.
Operative Technique
All 343 patients underwent descending thoracic or thoracoabdominal
aortic replacement with DHCA. The details of this technique are very im-
portant and have been previously published.12 Important technical consid-
erations included the following: (1) hypothermia for organ protection
with minimization of circulatory arrest time to any given vascular bed
or end organ, including the spinal cord; (2) avoidance of placing a proxi-
mal aortic crossclamp unless the inside of the aorta has been visually in-
spected during the period of circulatory arrest; (3) aggressive use of
bypasses to stenotic visceral or renal arteries; (4) placement of saphenous
vein bypass grafts to significantly diseased coronary arteries in the left an-
terior descending or circumflex distributions; (5) aggressive preservation
of important intercostal artery pairs by reimplantation into the side of the
graft or incorporation with proximal or distal anastomoses; (6) avoidance
of air and particulate emboli during the periods of cardiopulmonary by-
pass and circulatory arrest; and (7) cautious manipulation of the left
lung during the period of anticoagulation and adequate decompression
of the left ventricle during hypothermic bypass to avoid left lung paren-
chymal hemorrhage.
A total arch replacement was defined as resection of the entire trans-
verse arch with a proximal anastomosis to the ascending aorta or previous
ascending aortic graft. Arch vessels were reimplanted as an island or indi-
vidually bypassedwith a branched graft (Hemashield; Maquet, Inc,Wayne,
NJ; and Vascutek; Terumo Medical Corporation, Somerset, NJ). A partial
arch replacement involved resection of the arch proximal to the ligamen-
tum arteriosum with or without a bypass to the left subclavian artery. A by-
pass to the celiac artery, superior mesenteric artery (SMA), or renal artery
was defined as the use of a polytetrafluoroethylene interposition graft (W.
L. Gore & Associates, Inc, Flagstaff, Ariz) to reach proximal to an arterial
stenosis. Simple reimplantation of a vessel with an aortic button was not
considered to be a bypass. Coronary artery bypass with saphenous vein
was performed in descending thoracic and type I or II thoracoabdominal
aortic replacements when appropriate left anterior descending or circum-
flex targets had significant disease.RESULTS
The patient characteristics are listed in Table 1. The mean
agewas 66.0 12.3 years. Men comprised 63.6% of the pa-
tient population. Previous abdominal aortic replacement
had occurred in 24.5% of patients, and previous thoracic
aortic replacement had occurred in 24.8%. Chronic renal
insufficiency was seen in 15.5% of patients, with overt
renal failure in 7.3%. The aortic pathologic indications
included atherosclerotic aneurysm in 61.5%, chronic dis-
section with aneurysmal degeneration in 27.1%, and acute,
complicated type III dissection in 3.8%. Emergency or ur-
gent operations were performed in 13.1% for acute compli-
cated type III dissection, rupture or impending rupture of
DTAs or TAAAs, or acute aortic thrombosis.
The operative characteristics are listed in Table 2. Of the
343 operations, replacement of the descending thoracic aortaiovascular Surgery c Volume 140, Number 6S S155
TABLE 1. Patient characteristics (n ¼ 343)
Age (y, mean  SD) 66.0  12.3
Male 218 (63.6%)
Previous myocardial infarction 45 (13.1%)
Previous percutaneous coronary intervention 32 (9.3%)
Previous coronary artery bypass grafting 60 (17.5%)
Hypertension 311 (90.7%)
Chronic obstructive pulmonary disease 90 (26.2%)
Previous or current tobacco use 148 (43.1%)
Hyperlipidemia 137 (39.9%)
Diabetes mellitus 42 (12.2%)
Previous abdominal aortic surgery 84 (24.5%)
Previous thoracic aortic surgery 85 (24.8%)
Chronic renal insufficiency 53 (15.5%)
Previous renal failure 25 (7.3%)
Preoperative mesenteric ischemia 9 (2.6%)
Preoperative paraplegia 5 (1.5%)
Chronic dissection (type I or III) 93 (27.1%)
Acute type III dissection 13 (3.8%)
Degenerative aneurysm 211 (61.5%)
Pseudoaneurysm 18 (5.2%)
Infected aortic graft 10 (2.9%)
Coarctation 7 (2.0%)
Emergency or urgent operation 45 (13.1%)
Data represent numbers and percentages of patients except as marked.
Aortic Symposium 2010 Fehrenbacher et alwas involved in 28.6%, Crawford type I TAAA in 20.1%,
type II in 32.4%, type III in 9.3%, and type IVin 9.6%. Total
arch replacement was performed in 5.5% of all patients and
in 15.3% of DTA cases, 4.3% of type I TAAA cases, and
0.9% of type II TAAA cases. Partial arch replacement was
performed in 23.6% of all patients and 60.2% of DTATABLE 2. Operative characteristics (n ¼ 343)
Extent of aortic replacement
Descending thoracic aorta 98 (28.6%)
Type I thoracic aortic aneurysm 69 (20.1%)
Type II thoracic aortic aneurysm 111 (32.4%)
Type III thoracic aortic aneurysm 32 (9.3%)
Type IV thoracic aortic aneurysm 33 (9.6%)
Total arch 19 (5.5%)
Partial arch 81 (23.6%)
Other procedures
Celiac bypass 10 (2.9%)
Superior mesenteric artery bypass 6 (1.7%)
Celiac and superior mesenteric artery bypasses 15 (4.4%)
Left renal artery bypass 33 (9.6%)
Right renal artery bypass 19 (5.5%)
Left and right renal artery bypasses 22 (6.4%)
Coronary artery bypass 15 (4.4%)
Reimplantation of intercostal arteries 117 (34.1%)
Femoral cannulation 285 (83.1%)
Circulatory arrest time (min, mean  SD) 27.5  13.1
Cardiopulmonary bypass time (min, mean  SD) 242.6  80.3
Data represent numbers and percentages of patients except as marked.
S156 The Journal of Thoracic and Cardiovascular Surcases, 14.5% of type I cases, and 10.8% of type II cases
(see Table 3).
Of the patients with type II TAAA, 18 (16.2%) had
a celiac or SMA bypass or both and 50 (45.0%) had at least
1 renal artery bypass. Of the patients with type III TAAA,
7 (21.9%) had a celiac or SMA bypass or both and
12 (37.5%) had at least 1 renal artery bypass. Of the patients
with type IV TAAA, 5 (15.2%) had a celiac or SMA bypass
or both and 12 (36.4%) had at least 1 renal artery bypass.
Coronary artery bypass grafting with saphenous vein grafts
was performed in 7 DTA cases (7.1%), 5 type I TAAA cases
(7.2%), 2 type II cases (1.8%), and 1 type III case (3.1%).
Circulatory arrest time to the brain and heart was 27.5 
13.1 minutes. Total cardiopulmonary bypass time was
242.6  80.3 minutes.
In-hospital mortality was 5.0% for all patients. Perma-
nent paraplegia or paresis occurred in 3.2%. Permanent
cerebrovascular accident occurred in 4.4%. Dialysis-
dependent renal failure occurred in 1.5% (Table 4). Major
morbidities and mortalities by extent of aortic replacement
are listed in Table 3. Not surprisingly, type II TAAA oper-
ations carried the highest morbidity and mortality, with an
operative mortality of 9.0%, a permanent stroke rate of
6.3%, a permanent paraplegia or paresis rate of 5.4%,
and a dialysis-dependent renal failure rate of 1.8%. Emer-
gency and urgent operations also carried significant morbid-
ity and mortality, with an operative mortality of 13.3% and
permanent spinal cord ischemia in 4.4%, permanent stroke
in 8.9%, and renal failure requiring dialysis in 2.2%. Elec-
tive operations carried less major morbidity and mortality,
with an operative mortality of 3.7% and permanent stroke
in 3.7%, permanent spinal cord ischemia in 3.0%, and
dialysis-dependent renal failure in 1.3%.
Kaplan–Meier survival data are shown in Table 5 and
graphically depicted in Figure 1. Overall 1-, 5- and
10-year survivals were 90.1%, 69.3%, and 53.5%, respec-
tively. For patients who underwent elective DTA or TAAA
repair, 1-, 5-, and 10-year survivals were 91.6%, 70.7%,
and 54.3%, respectively. For patients who underwent emer-
gency or urgent repair, 1- and 5-year survivals were 79.6%
and 55.7%, respectively. Long-term survival appeared to be
greatest among those patients with isolated DTA, with or
without arch aneurysm (74.9% at 10 years).
Operative mortality and Kaplan–Meier survival data for
patients according to decade of age at the time of surgery
are shown in Table 6. For patients younger than 50 years,
operative mortality was 0%, and 10-year survival was
97.3%. For patients 80 years old and older (n ¼ 31), oper-
ative mortality was 16.1%; however, there are 2 octogenar-
ians who have survived at least 10 years after their
aneurysm repair.
The rate of reexploration for postoperative bleeding was
5.0% for all patients. Prolonged intubation was a complica-
tion in 11.4% of all patients. Tracheostomy was necessarygery c December 2010
TABLE 3. Major morbidity and mortality by extent of repair and acuity of operation
DTA
Type I
TAAA
Type II
TAAA
Type III
TAAA
Type IV
TAAA
DTAþType I
TAAA Elective
Emergency
or urgent
No. 98 69 111 32 33 167 298 45
Arch replacement
Total 15 (15.3%) 3 (4.3%) 1 (0.9%) 0 (0%) 0 (0%) 18 (10.8%) 17 (5.7%) 2 (4.4%)
Partial 59 (60.2%) 10 (14.5%) 12 (10.8%) 0 (0%) 0 (0%) 69 (41.3%) 69 (23.2%) 12 (26.7%)
Operative mortality 3 (3.1%) 1 (1.4%) 10 (9.0%) 2 (6.3%) 1 (3.0%) 4 (2.4%) 11 (3.7%) 6 (13.3%)
Dialysis-dependent renal failure 0 (0%) 1 (1.4%) 2 (1.8%) 1 (3.1%) 1 (3.0%) 1 (0.6%) 4 (1.3%) 1 (2.2%)
Permanent paralysis or paresis 1 (1.0%) 3 (4.3%) 6 (5.4%) 1 (3.1%) 0 (0%) 4 (2.4%) 9 (3.0%) 2 (4.4%)
Permanent cerebrovascular
accident
4 (4.1%) 2 (2.9%) 7 (6.3%) 1 (3.1%) 1 (3.0%) 6 (3.6%) 11 (3.7%) 4 (8.9%)
Tracheostomy 5 (5.1%) 2 (2.9%) 5 (4.5%) 0 (0%) 0 (0%) 7 (4.2%) 10 (3.4%) 2 (4.4%)
Data represent numbers and percentages of patients except as marked. DTA, Descending thoracic aneurysm; TAAA, thoracoabdominal aneurysm.
TABLE 4. Operative results (n ¼ 343)
In-hospital mortality 17 (5.0%)
Mortality within 30 d 15 (4.4%)
Permanent cerebrovascular accident 15 (4.4%)
Transient cerebrovascular accident 10 (2.9%)
Permanent paraplegia or paresis 11 (3.2%)
Transient spinal cord ischemia 13 (3.8%)
Postoperative lumbar drain 17 (5.0%)
Acute renal failure 17 (5.0%)
Dialysis-dependent renal failure 5 (1.5%)
Myocardial infarction 4 (1.2%)
Gastrointestinal complications 12 (3.5%)
Tracheostomy 12 (3.5%)
Prolonged intubation 39 (11.4%)
Reintubation 40 (11.7%)
Reexploration for bleeding 17 (5.0%)
Transfusion (units, mean  SD)
Packed red blood cells 4.7  5.2
Fresh-frozen plasma 4.6  3.9
Platelet pheresis 1.9  2.4
Cryoprecipitate (10 units) 10.4  7.0
Postoperative stay (d, mean  SD) 11.8  9.8
Data represent numbers and percentages of patients except as marked.
Fehrenbacher et al Aortic Symposium 2010in 3.5% of patients. Mean postoperative stay was 11.8 9.8
days, with a median of 9 days.
DISCUSSION
Despite the mortality risk with the surgical repair of
DTAs and TAAAs, repair remains beneficial relative to
the natural history of untreated aneurysms. Left untreated,
these aneurysms carry an estimated 5-year survival of
only 18% to 46%.19,20
Hypothermic cardiopulmonary bypass for DTA and
TAAA repair requires a strong command of pump manage-
ment techniques and is used by other centers, especially in
the repair of extensive or complex TAAAs.12-18 Soukiasian
and colleagues15 and Okita and associates17 achieved im-
proved results by adopting DHCA as the sole technique of
TAAA repair. Although their results were surprising to
Etz and coworkers,18 we have found, as they did, that hypo-
thermia and circulatory arrest are not only useful in reoper-
ative thoracic and thoracoabdominal procedures but central
to achieving excellent results in this difficult patient popu-
lation.18 One luxury of circulatory arrest is the avoidance
of the difficult exposures that would be necessary if one
were to place clamps while using other techniques, such
as left heart bypass or ‘‘clamp and sew.’’ The ability to vi-
sualize the inside of the arch during the period of circulatory
arrest gives the surgeon the ability to avoid or remove se-
verely atherosclerotic segments, perform endarterectomy
of very calcified segments, and assess the need for arch
branch bypasses or total arch replacement. In the combined
group of DTA, type I, and type II repairs, 29.1% required
a partial arch replacement, 6.8% a total arch replacement,
and 11.1% a left subclavian artery bypass. DHCA affords
the time and cerebral protection needed to accomplish these
proximally extended repairs safely.
Other authors are cautious about the routine use of
DHCA in DTA and TAAA repairs because of their own ex-
perience and results.21-23 Safi and colleagues21 used this
technique when a proximal clamp could not be placed or
when ‘‘catastrophic bleeding’’ complicated the procedure.The Journal of Thoracic and CardThat group reported a 29% mortality with DHCA and
a 67% rate of pulmonary complications, including a 10%
rate of left pneumonectomy for uncontrolled pulmonary
hemorrhage, and a 32% rate of neurologic injury. In that se-
ries, 6 of 21 cases were emergency operations, with a 50%
mortality in that subset of patients. Coselli and coworkers22
reported a 28% mortality and morbidity rates of 9% for
stroke, 15% for renal failure, and 22% for tracheostomy
in a series of 111 patients, 102 of whom required emergency
or urgent operation. Certainly, emergency or urgent opera-
tions overall carry significant morbidity and mortality, re-
gardless of the operative technique. We have found that
uncontained aortic rupture is a situation in which DHCA
is not advantageous unless the bleeding is controlled and
the entire body is sufficiently perfused and cooled. In addi-
tion, we have avoided major pulmonary hemorrhageiovascular Surgery c Volume 140, Number 6S S157
TABLE 5. Kaplan–Meier survival estimates by extent of repair and acuity of operation
All DTA Type I TAAA Type II TAAA Type III TAAA Type IV TAAA Elective
Emergency
or urgent
No. 343 98 69 111 32 33 298 45
Survival (%)
1 y 90.1% 94.8% 92.5% 83.2% 90.5% 93.7% 91.6% 79.6%
3 y 79.4% 87.6% 87.0% 69.6% 79.8% 73.5% 80.2% 75.2%
5 y 69.3% 80.2% 73.4% 59.2% 65.4% 73.5% 70.7% 55.7%
7 y 62.9% 74.9% 64.0% 54.4% 58.9% 66.2% 63.9% 55.7%
10 y 53.5% 74.9% 53.3% 43.0% 44.2% 49.6% 54.3% 55.7%
DTA, Descending thoracic aneurysm; TAAA, thoracoabdominal aneurysm.
Aortic Symposium 2010 Fehrenbacher et althrough adequate decompression of the left ventricle, usu-
ally by direct drainage, and careful manipulation of the
lung during the period of hypothermia and anticoagulation.
Our results with type II TAAA repair compare favorably
with published studies from specialized aortic centers that
use many techniques.24-27 Operative mortality for type II
repair in our series was 9.0%, which compares favorably
with other published studies, which have a range from
10% to 22%. Permanent spinal cord injury in our series
was 5.4% without the routine use of lumbar drains. Other
studies have reported paraplegia or paraparesis rates from
7% to 22%. The greatest difference in outcome between
our series with DHCA and others was in renal failure and
renal failure requiring dialysis. Our incidence of renal
failure in type II TAAA repair was 7.2%, with 1.8%
requiring dialysis. Other studies have shown renal failure
rates from 16% to 22%, with postoperative dialysis rates
of 8.5% to 21%. We believe that end-organ protection is
imperative in extensive type II aortic repairs. Deep hypo-
thermic cardiopulmonary bypass protects the spinal cord
and kidneys and allows adequate time for complex and
extensive repairs.Pe
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FIGURE 1. Kaplan–Meier survival curve for all patients (n ¼ 343).
S158 The Journal of Thoracic and Cardiovascular SurWe also use DHCA in the repair of Crawford type IV
TAAAs. Other series have reported operative mortalities
of 6% to 13%, with rates of acute renal failure requiring
dialysis of 6% to 12% and of paraplegia of 2% to 5%,
predominantly with the clamp and sew method.28-30 In
our series, isolated Crawford type IV TAAAs carried an
operative mortality of 3%, a dialysis-dependent renal fail-
ure rate of 3%, a stroke rate of 3%, and a paraplegia rate
of 0%. Of these patients, 6% had SMA bypass, 9% had
both celiac and SMA bypasses, 12% had left renal artery
bypass, 6% had right renal artery bypass, and 18% had bi-
lateral renal artery bypasses. Deep hypothermia protects
end organs, as well as affording the surgeon time to perform
bypasses of stenotic visceral or renal vessels. The ability to
achieve uncompromised revascularization of the viscera
and kidneys with limited ischemic damage is one of the
strengths of this technique.
Thoracic endograft repair, although much less invasive
and often an enticing option in this patient population, still
carries significant neurologic morbidity and mortality, with
no long-term data available regarding survival or dura-
bility of the repair.31-33 Visceral debranching followed by
thoracoabdominal endograft exclusion carries significantly
high morbidity and mortality and has been largely
abandoned as a first option for TAAA repair.2,34 Custom-
made branched endografts have promise, but they are not
commercially available in theUnited States, have significant
rates of reintervention, and do not have long-term follow
up.35,36 In our combined Crawford type II, III, and IV
TAAA groups, which had aortic disease comparable to that
in the hybrid and branched endograft candidates, mortality
was 7.4%, permanent stroke rate was 4.5%, paraplegia
rate was 4.0%, and new dialysis renal failure rate was
2.3%. The rate of reintervention in these open surgical
cases was 3.9%, with reintervention typically needed for
pseudoaneurysm formation or replacement of an infected
graft. Our results are comparable to the early results of
branched endograft procedures, are superior to the results
of hybrid endograft repairs, and have significantly lower
rates of reintervention.2,34-36gery c December 2010
TABLE 6. Operative mortality and Kaplan–Meier survival estimates by decade of age at the time of operation
All <50 y 50–59 y 60–69 y 70–79 y 80–89 y
Mean age (y, mean  SD) 66.0  12.3 40.4  6.7 55.2  2.9 64.5  2.7 74.4  2.9 82.2  2.0
No. 343 38 46 95 133 31
In-hospital mortality (%) 5.0% 0% 4.3% 4.2% 4.5% 16.1%
Survival (%)
1y 90.1% 97.3% 91.3% 87.3% 91.5% 80.4%
3 y 79.4% 97.3% 88.3% 74.6% 77.3% 68.6%
5 y 69.3% 97.3% 80.9% 61.9% 64.5% 61.7%
7 y 62.9% 97.3% 80.9% 56.0% 52.9% 61.7%
10 y 53.5% 97.3% 64.8% 41.5% 43.0% 61.7%
Fehrenbacher et al Aortic Symposium 2010Surgeons have used ‘‘chimney’’ or ‘‘snorkel’’ stents to ex-
tend the application of thoracic endovascular aortic repair to
patients with aortic anatomy that is not suitable with regard
to the landing zones. The placement of chimney stents into
the supra-aortic arch branches, visceral, and renal arteries to
gain landing zone length does not yet have long-term effi-
cacy or long-term survival data.37,38 Regardless of the
complexity of thoracic endograft procedures, they will
always have inherent anatomic limitations regarding the
length and quality of the landing zones and the patency or
proximity of aortic branches. These limitations are not an
issue in open repair, especially with DHCA.
Although it is a common practice to place endografts in
chronic aortic dissections, long-term efficacy has not been
reported. Furthermore, the use of thoracic endografts in
chronic aortic dissections may not reduce the risk of aortic
rupture or improve survival.39 It is difficult to conceive how
an endoluminal graft of a lesser length will be able to ade-
quately and consistently treat an extensive aortic dissection
with multiple points of reentry distal to the repair. We have
chosen to repair all chronic dissections with our open tech-
nique. In 49 patients with chronic dissections who under-
went DTA or type I TAAA repair, our mortality was
2.0%, our paraplegia rate was 0%, our stroke rate was
0%, our rate of renal failure requiring dialysis was 0%,
and our reintervention rate was 2.0%. Because of the suc-
cess of open repair with DHCA in this particular subset of
patients and the uncertainty of endoluminal repair for this
aortic pathology, we will continue to repair chronic dissec-
tions with our open technique.
Pulmonary complications are still the most common
postoperative complications of DTA and TAAA repair;
however, most are temporary. Prolonged intubation affected
7.1% of patients with DTA repairs and 13.1% of patients
with TAAA repairs. In our series, only a few patients re-
quired tracheostomies, none of which were permanent in
the operative survivors. Significant pulmonary hemorrhage
related to coagulopathy can be a major morbidity but has
been an infrequent and reversible problem in our series.
No patients required lung resection for intractable intrapar-
enchymal pulmonary hemorrhage.The Journal of Thoracic and CardOur 5-year survival of 69% for our surgically treated pa-
tients is clearly better than the 13% 5-year survival of all
patients with untreated thoracic aneurysms reported by
Bickerstaff and associates.40 The general population in
that study had a 5-year survival of 75%. Coady and
colleagues41 found that 5-year survival of a more contem-
porary population of patients with DTAs was 39%, whether
or not they were surgically treated. The 5-year survival in an
age and sex-matched population was 80%. Repair of DTA
and TAAAwith DHCA provides survival at 5 years similar
to that of the general population and superior to that of pa-
tients with nonoperative aneurysm management.
Our 10-year survival of 54% overall compares favorably
with those of other surgical series showing 10-year sur-
vivals of 29% to 38%.7,8,10,42 We attribute the excellent
long-term survival to the intensive preoperative cardiac
screening, including coronary catheterization in all patients
and insistence on coronary revascularization either preoper-
atively or intraoperatively as part of the aneurysm repair.
Our patients undergoing DTA repair had the greatest
long-term survival of 75% at 10 years. Additionally, we
had a low rate of reintervention (2.9%) for pseudoaneurysm
or graft infection. It is our practice to follow up with serial
computed tomographic scans for several years after repair
to assess the need for reoperation on repaired aortic seg-
ments or for extension of the repair for continued aneurys-
mal degeneration of adjacent aortic segments.
Our study has the inherent limitations of a high-volume,
single-institution, 2-surgeon, retrospective study. Our sur-
vival data are based in part on the completeness of the So-
cial Security death index. Although we acknowledge that
we may have lost some patients to follow-up, most patients
who continue to reside in Indiana are referred back to our
institution for new problems or continuing follow-up of
the thoracoabdominal aorta.
In summary, the use of open repair with DHCA, although
a complex technique, can provide low mortality and mor-
bidity in the repair of descending thoracic and TAAAs.
We believe that this technique can be safely used by more
surgeons in the future and become a benchmark for devel-
opment of new techniques and technologies.iovascular Surgery c Volume 140, Number 6S S159
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